Navigation Links
Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
Date:2/29/2008

MADISON, N.J., Feb. 29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the end of its collaboration agreements with Solvay Pharmaceuticals for the development and commercialization of bifeprunox as well as other compounds in earlier stages of development for the potential treatment of schizophrenia and other psychiatric conditions.

Wyeth terminated the collaboration with Solvay after assessing the opportunity for bifeprunox and determining it would not have sufficient commercial value for the two companies to share.

All development and commercialization rights in North America for bifeprunox, an investigational atypical antipsychotic, as well as global rights for the other compounds will now revert to Solvay Pharmaceuticals.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events and are subject to risks and uncertainties that could cause actual results to
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Wyeth Announces Executive Change in Finance Organization
2. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
3. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
5. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
6. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
7. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
8. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
9. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
10. Wyeth Declares Preferred Stock Dividend
11. Wyeth Announces Election of New Principal Corporate Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...5 BioSpecifics Technolog...mpany developing first-in-class collagenase-based ...r the third quarter ended September 30, 2009. ,...this year, the FDA,s Arthritis Advisory Committee ...proval of XIAFLEX(TM) for the treatment of Dupuytr...
(Date:11/5/2009)... 5 WaferGen Biosystems, ...er of state-of-the-art genetic analysis systems, t...oined the company,s Scientific Advisory Board. Hi...ializing novel molecular diagnostics for cancer de...ment of computational biology systems for several ...
(Date:11/5/2009)...ASIK Surgery and vision correction experts listed ...ely involved at the recently concluded American Ac...n San Francisco, California. Dr. Stephen Brint, MD...dorf, MD, Dr. Peter Rapoza, MD, Dr. Michael Raizma..., MD, Dr. Edward Manche, MD, and Dr. Parag Majmuda...
(Date:11/4/2009).... 4 DIATHERIX Laboratories, Inc. (...d at the Michigan Security Network Homeland Securi... Dennis Grimaud, Chairman and Chief Executive Offi...any,s advanced molecular diagnostic testing on bio...se diagnosis and military efforts. ,, "This co...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9DIATHERIX Laboratories Presents at Homeland Security Conference 2
... To validate any RNAi experiment...d be confirmed and quantitated. Validation, , ... is known to be effective, , is...ers. , Validation is also neces...fectiveness and potency of any siRNA sequence. Fin...
...ActivePro In Vitro Translation Kit , ...protein than reticulocyte , lysate system...protein translation , Higher biologica...ate systems , Easy to use , Fo... protein-protein interactions, Ambio...
... RNA quality is a critical determinant for ,... applications, including , micr...ing , microarray analysis exper... consider the factors that affect the quality o...ic Responses to Injury , Affect...
Other Biology Technology:Confirming RNAi Effects Is Now Easier Than Ever 2Confirming RNAi Effects Is Now Easier Than Ever 3Confirming RNAi Effects Is Now Easier Than Ever 4Confirming RNAi Effects Is Now Easier Than Ever 5Increase Protein Activity and Yield 2Increase Protein Activity and Yield 3Determinants of RNA Integrity and Purity 2Determinants of RNA Integrity and Purity 3Determinants of RNA Integrity and Purity 4Determinants of RNA Integrity and Purity 5Determinants of RNA Integrity and Purity 6Determinants of RNA Integrity and Purity 7
(Date:11/4/2009)...stCall/ -- BIO-key International, Inc. (OTC Bullet...c identification software is showcasing donor and ...ence being held at the New Orleans Convention Cent...ands-on product demonstrations of its state-of-the..., at 5 PM on Monday, October 26, Peter Lux, manage...
(Date:11/3/2009)...world,s greatest wines are the result of a threefo...omething called the "terroir" -- a term often defi... Experts will discuss terroir with an emphasis on ...n Pittsburgh. "Terroir: Winegrapes and the Enviro...Annual Meetings of the American Society of Agronom...
(Date:11/3/2009)... much as 28 percent less likely to become pregnant...earch that earned a Michigan State University prof...a Luke, a researcher in the MSU College of Human M... Reproductive Biology, focused on data of nearly 5.... , Luke,s findings, which also can be applied t...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Great wines come from great soils 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 1Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 2Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 3Agent Orange Linked to Parkinsons Heart Disease 52680 1Agent Orange Linked to Parkinsons Heart Disease 52680 2Agent Orange Linked to Parkinsons Heart Disease 52680 3Agent Orange Linked to Parkinsons Heart Disease 52680 4San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 6 Million This Year to Community Outreach Programs 52677 1San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 6 Million This Year to Community Outreach Programs 52677 2San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 6 Million This Year to Community Outreach Programs 52677 3San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 6 Million This Year to Community Outreach Programs 52677 4
...f obesity in the U.S. states has been greatly unde...ublic Health (HSPH) analyzed data from health surv...states. Because people tend to provide incorrect i...ly in telephone surveys, the researchers concluded...ve been too low, by more than 50%. Their study, wh...
...same yield/acre, use fewer chemical insecticides a...e biotech cotton known as Bt cotton, according to ...arge-scale study that simultaneously examined how ... biodiversity. It,s good news for the environment....zona -- no doubt about it," said Yves Carrière, an...
..." may hit closer to the mark than we suspected. ...ersity of California, San Diego, and published in ...t that judgments of attractiveness depend on menta..., "What you like is a function of what your mind ... becomes attractive if it falls into the average o...
Other Biology News:Obesity levels in US are grossly underestimated 2Biotech cotton provides same yield with fewer pesticides 2Biotech cotton provides same yield with fewer pesticides 3Beauty and the brain 2Beauty and the brain 3
Rat CXCL7 (NAP-2) ELISA development Kit, DuoSet Economy Pack from R&D Systems
X-Gal from GE Healthcare, formerly Amersham Biosciences
Rat Fas, Unconjugated from R&D Systems
RABBIT (NORMAL) COMPLEMENT from AbD Serotec
Biology Products: